These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 5778194)

  • 21. Neurophysiological and neuropsychological differences related to performance and verbal abilities in subjects with mild intellectual disability.
    Muñoz-Ruata J; Gómez-Jarabo G; Martín-Loeches M; Martínez-Lebrusant L
    J Intellect Disabil Res; 2000 Oct; 44 ( Pt 5)():567-78. PubMed ID: 11079354
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Suicide linked to homicide.
    Virkkunen M
    Psychiatr Q; 1974; 48(2):276-82. PubMed ID: 4438481
    [No Abstract]   [Full Text] [Related]  

  • 23. Cognitive impairments in schizophrenic patients with hyponatremia.
    Schnur DB; Wirkowski E; Reddy R; Decina P; Mukherjee S
    Biol Psychiatry; 1993 Jun 1-15; 33(11-12):836-8. PubMed ID: 8373921
    [No Abstract]   [Full Text] [Related]  

  • 24. Paranoia Symptoms Moderate the Impact of Emotional Context Processing on Community Functioning of Individuals with Schizophrenia.
    Park K; Choi KH
    Community Ment Health J; 2018 Oct; 54(7):1064-1070. PubMed ID: 29700666
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Positive symptoms and social cognition impairment affect severity of suicidal ideation in schizophrenia.
    Comparelli A; Corigliano V; Lamis DA; De Carolis A; Stampatore L; De Pisa E; Girardi P; Pompili M
    Schizophr Res; 2018 Mar; 193():470-471. PubMed ID: 28712966
    [No Abstract]   [Full Text] [Related]  

  • 26. Schizophrenia: measurements of psychopathology.
    Lindenmayer JP; Harvey PD; Khan A; Kirkpatrick B
    Psychiatr Clin North Am; 2007 Sep; 30(3):339-63. PubMed ID: 17720027
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gender differences in cognitive function of patients with chronic schizophrenia.
    Han M; Huang XF; Chen DC; Xiu MH; Hui L; Liu H; Kosten TR; Zhang XY
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Dec; 39(2):358-63. PubMed ID: 22820676
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Performance on the Cognitive Estimation Test in schizophrenia.
    Roth RM; Pixley HS; Kruck CL; Garlinghouse MA; Giancola PR; Flashman LA
    Appl Neuropsychol Adult; 2012; 19(2):141-6. PubMed ID: 23373582
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Course of cognitive deficits in first episode of non-affective psychosis: a 3-year follow-up study.
    Rodríguez-Sánchez JM; Ayesa-Arriola R; Pérez-Iglesias R; Periañez JA; Martinez-Garcia O; Gomez-Ruiz E; Tabares-Seisdedos R; Crespo-Facorro B
    Schizophr Res; 2013 Oct; 150(1):121-8. PubMed ID: 23899999
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Speed of perceptual functioning in chronic nonparanoid schizophrenics.
    Yates AJ; Korboot P
    J Abnorm Psychol; 1970 Dec; 76(3):453-61. PubMed ID: 5490713
    [No Abstract]   [Full Text] [Related]  

  • 31. The association among smoking, HSV-1 exposure, and cognitive functioning in schizophrenia, bipolar disorder, and non-psychiatric controls.
    Dickerson F; Adamos MB; Katsafanas E; Khushalani S; Origoni A; Savage CLG; Schroeder J; Schweinfurth LAB; Stallings C; Sweeney K; Yolken R
    Schizophr Res; 2016 Oct; 176(2-3):566-571. PubMed ID: 27262384
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of tapering of long-term benzodiazepines on cognitive function in patients with schizophrenia receiving a second-generation antipsychotic.
    Kitajima R; Miyamoto S; Tenjin T; Ojima K; Ogino S; Miyake N; Fujiwara K; Funamoto Y; Arai J; Tsukahara S; Ito Y; Tadokoro M; Anai K; Kaneda Y; Yamaguchi N
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Mar; 36(2):300-6. PubMed ID: 22122880
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Determinants of work outcome in schizophrenia and schizoaffective disorder: role of cognitive function.
    Kaneda Y; Jayathilak K; Meltzer HY
    Psychiatry Res; 2009 Sep; 169(2):178-9. PubMed ID: 19646764
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thought disorder severity in compromised, deteriorated, and preserved intellectual course of schizophrenia.
    Mercado CL; Johannesen JK; Bell MD
    J Nerv Ment Dis; 2011 Feb; 199(2):111-6. PubMed ID: 21278540
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adjunctive yokukansan treatment improved cognitive functions in a patient with schizophrenia.
    Sakamoto S; Ujike H; Takaki M; Mizuki Y; Okahisa Y; Kodama M; Uchitomi Y
    J Neuropsychiatry Clin Neurosci; 2013; 25(3):E39-40. PubMed ID: 24026738
    [No Abstract]   [Full Text] [Related]  

  • 36. Effect of intrinsic motivation on cognitive performance in schizophrenia: a pilot study.
    Fervaha G; Agid O; Foussias G; Remington G
    Schizophr Res; 2014 Jan; 152(1):317-8. PubMed ID: 24333003
    [No Abstract]   [Full Text] [Related]  

  • 37. Re: Correlation between cognitive functioning and the symptomatology of schizophrenia.
    Stip E
    Can J Psychiatry; 1998 Oct; 43(8):854-5. PubMed ID: 9806094
    [No Abstract]   [Full Text] [Related]  

  • 38. Psychiatric morbidity in the first-degree relatives of schizophrenic patients.
    Varma SL; Sharma I
    Br J Psychiatry; 1993 May; 162():672-8. PubMed ID: 8149120
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuropsychological performance in first-episode adolescents with schizophrenia: a comparison with first-episode adults and adolescent control subjects.
    White T; Ho BC; Ward J; O'Leary D; Andreasen NC
    Biol Psychiatry; 2006 Sep; 60(5):463-71. PubMed ID: 16566898
    [TBL] [Abstract][Full Text] [Related]  

  • 40. How specific are negative symptoms and cognitive impairment in schizophrenia? An analysis of PANSS and SCoRS.
    Cruz BF; de Resende CB; Abreu MN; Rocha FL; Teixeira AL; Keefe RS; Salgado JV
    Cogn Neuropsychiatry; 2013 May; 18(3):243-51. PubMed ID: 23145794
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.